Skip to main content
Erschienen in: PharmacoEconomics 3/2002

01.12.2002 | Current Opinion

The Prospects for Reform of the Japanese Healthcare System

verfasst von: Professor Tadahiko Tokita

Erschienen in: PharmacoEconomics | Sonderheft 3/2002

Einloggen, um Zugang zu erhalten

Abstract

It is widely recognised that the Japanese healthcare system has been ranked as one of the best in the world because of its excellent efficiency and equity. The longevity and low infant mortality of the Japanese population have been achieved with a relatively low ratio of health expenditure to gross domestic product. All Japanese are covered by universal medical care insurance and all are provided with completely free access to the same medical care.
Nevertheless, it should be pointed out that the medical care service is not as good as it looks. Owing to lack of competition between both hospitals and powerless insurers — the outcome of too many regulations — there is only a small incentive to improve the efficiency and quality of medical service. Furthermore, because of Japan’s rapidly aging society and low birth rate, together with the long depression the economy has experienced, it is very difficult to maintain the ‘pay-as-you-go’ health system.
For health system reform, our proposals are as follows: deregulating health markets, including pharmaceutical markets; strengthening the role of insurers; introducing information technology; and restructuring the healthcare of the elderly. We are expecting the new cabinet, which enjoys much popularity, to have the courage to initiate health reform along these lines, in spite of opposition from powerful interest groups, bureaucrats, and even members of ruling parties.
Fußnoten
1
Of the many papers and books concerning reference pricing, one of the most noteworthy may be the paper by Dickson and Redwood.[9]
 
Literatur
1.
Zurück zum Zitat Ministry of Health, Labor andWelfare (MHLW). Annual report on health and welfare 1998–1999: social security and national life. Tokyo, Japan: International Corporation of Welfare Services, MHLW, 2000 Ministry of Health, Labor andWelfare (MHLW). Annual report on health and welfare 1998–1999: social security and national life. Tokyo, Japan: International Corporation of Welfare Services, MHLW, 2000
2.
Zurück zum Zitat Tokita T. Health policy in Japan: from the view point of public economics [in Japanese]. Econ Rev 2001; 52 (3): 205–19 Tokita T. Health policy in Japan: from the view point of public economics [in Japanese]. Econ Rev 2001; 52 (3): 205–19
3.
Zurück zum Zitat Campbell JC, Ikegami N. The art of balance in health policy: maintaining Japan’s low-cost, egalitarian system. Cambridge: Cambridge University Press, 1998CrossRef Campbell JC, Ikegami N. The art of balance in health policy: maintaining Japan’s low-cost, egalitarian system. Cambridge: Cambridge University Press, 1998CrossRef
4.
Zurück zum Zitat Kawabuchi K. Introduction to health care economics in Japan: understanding Japanese health care reform. Tokyo, Japan: Yakuji-Nippo, 1998 Kawabuchi K. Introduction to health care economics in Japan: understanding Japanese health care reform. Tokyo, Japan: Yakuji-Nippo, 1998
5.
Zurück zum Zitat Tokita T, Chino T, Kitaki H, et al. The present and future national medical expenditure in Japan. Tokyo, Japan: Economic Research Institute, Economic Planning Agency, 1997 Tokita T, Chino T, Kitaki H, et al. The present and future national medical expenditure in Japan. Tokyo, Japan: Economic Research Institute, Economic Planning Agency, 1997
6.
Zurück zum Zitat Ministry of Health, Labor and Welfare (MHLW). Patient Survey [in Japanese]. Tokyo, Japan: Statistics and Information Department, Minister’s Secretariat, MHLW, 1993 Ministry of Health, Labor and Welfare (MHLW). Patient Survey [in Japanese]. Tokyo, Japan: Statistics and Information Department, Minister’s Secretariat, MHLW, 1993
7.
Zurück zum Zitat Tokita T, Nakayama N. Regulations in Japanese health market. Institute of economic research [in Japanese]. Tokyo, Japan: Hitotsubashi University, Mar 2001: Discussion paper No. 25 Tokita T, Nakayama N. Regulations in Japanese health market. Institute of economic research [in Japanese]. Tokyo, Japan: Hitotsubashi University, Mar 2001: Discussion paper No. 25
8.
Zurück zum Zitat Tokita T, Chino T, Kitaki T. Health expenditure and the measure determinants in Japan. Hitotsubashi J Econ 2000; 41 (1): 1–16 Tokita T, Chino T, Kitaki T. Health expenditure and the measure determinants in Japan. Hitotsubashi J Econ 2000; 41 (1): 1–16
9.
Zurück zum Zitat Dickson M, Redwood H. Pharmaceutical reference prices. How do they work in practice? Pharmacoeconomics 1998; 14 (5): 471–9PubMedCrossRef Dickson M, Redwood H. Pharmaceutical reference prices. How do they work in practice? Pharmacoeconomics 1998; 14 (5): 471–9PubMedCrossRef
10.
Zurück zum Zitat Tokita T. Towards the Japanese health reform for the patients and people [in Japanese]. J Health Care Soc 2001; 10 (4): 1–12 Tokita T. Towards the Japanese health reform for the patients and people [in Japanese]. J Health Care Soc 2001; 10 (4): 1–12
Metadaten
Titel
The Prospects for Reform of the Japanese Healthcare System
verfasst von
Professor Tadahiko Tokita
Publikationsdatum
01.12.2002
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe Sonderheft 3/2002
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200220003-00005

Weitere Artikel der Sonderheft 3/2002

PharmacoEconomics 3/2002 Zur Ausgabe

Concluding Remarks

Concluding Remarks